ÄKTA oligosynth oligonucleotide automatic synthesis device
A compact oligonucleotide synthesizer suitable for research, process development, and small-scale manufacturing.
ÄKTA oligosynt is a fully automated system for synthesizing oligonucleotides such as DNA and RNA. It builds a robust and scalable oligonucleotide synthesis process, supporting the transition to manufacturing with high synthesis efficiency and quality. ● Supports synthesis scales required for research and process development (up to 12 mmol) ● Equipped with up to 16 inlets for amidites ● Flow paths optimized to minimize hold-up volume ● Inert gas system eliminates the risk of moisture contamination in reagents and amidites ● All modules are accessible from the front, making purging and reactor installation operations simpler ● Equipped with the latest version of UNICORN software
basic information
For more details, please feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please feel free to contact us.
Recommended products
Distributors
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.